Synthaverse secures PLN 45 million loan. Synthaverse stock is valued at PLN 213.6 million

Published on 10/18/2026 at 13:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-half revenue reached PLN 26.46 million, up 34.20 percent year over year. The December 2, 2026 report sets a date for Synthaverse stock.

Financing and reporting timeline

Synthaverse received a PLN 45 million refinancing decision on October 16, 2026.
First-half revenue reached PLN 26.46 million, up 34.20 percent year over year.
Synthaverse stock was last quoted at PLN 2.81 on October 16, 2026 at 4:59 p.m. CEST.
The next earnings report is scheduled for December 2, 2026.

Biomed Lublin, PLBMDLB00018, Illustration mit AI erstellt.

Synthaverse stock (ISIN PLBMDLB00018) is valued at PLN 213.6 million after the company secured a PLN 45 million refinancing loan. The financing decision dated October 16, 2026 is designed to replace debt owed to ACP and reshape the company's funding structure, according to PAP.

What does the loan change?

The loan from Poland's Industrial Development Agency carries a financing period of up to 120 months and a principal repayment grace period of up to 24 months. Interest is set at WIBOR 1M plus a margin of 3.5 to 4.0 percentage points, with a possible reduction to 2.5 percentage points after net debt to EBITDA falls below 3.0, PAP reported on October 16, 2026.

Synthaverse also plans an equity issue and additional bank financing of PLN 10.50 million to PLN 11.50 million. Management estimates the completed refinancing could reduce annual financial costs by PLN 5.32 million, although the structure still depends on documentation, creditor agreements, security arrangements and new equity.

Revenue rose while losses widened

Chronology shows three key steps. On October 7, 2026, Synthaverse announced registration of Onko BCG in Paraguay, the second Latin American market for the product, according to Investing.com. On September 30, 2026, the company filed first-half figures showing revenue of PLN 26.46 million against PLN 19.71 million a year earlier, a 34.20 percent increase, while EBITDA rose to PLN 5.42 million from PLN 2.24 million. On October 16, 2026, the ARP refinancing decision added PLN 45 million to the financing plan.

Bankier.pl reported that first-half net loss reached PLN 6.37 million, compared with PLN 5.31 million in the prior-year period. The figures show the central tension for the stock: operating performance improved, while financing costs kept the bottom line negative.

When is the next report?

The next earnings report is scheduled for December 2, 2026, according to Investing.com. That date will give investors a checkpoint on revenue growth, cash generation and progress toward the proposed refinancing.

Stock stays tied to refinancing

On the Warsaw Stock Exchange, the last quoted price was PLN 2.81 on October 16, 2026 at 4:59 p.m. CEST. The next market assessment will weigh the financing plan against the company's PLN 6.37 million first-half net loss and planned equity issuance. The further course of trading is shown by the continuously updated real-time quote of Synthaverse stock.